Missionpharma
Missionpharma, officially known as Missionpharma A/S, is a leading provider of healthcare solutions headquartered in Denmark (DK). Established in 2000, the company has made significant strides in the pharmaceutical and medical supply industry, focusing on the procurement and distribution of essential medicines and medical devices across various regions, including Africa and Asia. With a commitment to improving healthcare access, Missionpharma offers a diverse range of products, including generic pharmaceuticals, surgical instruments, and diagnostic tools. Their unique approach combines quality assurance with competitive pricing, ensuring that healthcare providers receive reliable products tailored to their needs. Recognised for their dedication to social responsibility, Missionpharma has positioned itself as a trusted partner in global health initiatives, contributing to improved health outcomes in underserved communities.
DitchCarbon Score
How does Missionpharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Missionpharma's score of 31 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Missionpharma's reported carbon emissions
In 2023, Missionpharma reported carbon emissions of approximately 273,000 kg CO2e, all of which were classified under Scope 1. This marked an increase from 2022, where emissions were about 250,000 kg CO2e, also solely from Scope 1. In 2021, the company recorded emissions of around 162,000 kg CO2e, again from Scope 1. Notably, there have been no reported emissions from Scope 2 or Scope 3 in any of these years. Despite the increase in emissions over the past two years, Missionpharma has not disclosed any specific reduction targets or initiatives aimed at decreasing their carbon footprint. The absence of documented climate pledges or reduction strategies suggests that the company may still be in the early stages of formalising its climate commitments. As a company headquartered in Denmark (DK), Missionpharma operates within a global context where many organisations are increasingly prioritising sustainability and carbon reduction. However, without clear targets or initiatives, it remains to be seen how Missionpharma will align with industry standards for climate action in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 162,000 | 000,000 | 000,000 | 000,000 |
| Scope 2 | - | - | - | - |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Missionpharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
